Cargando…
ProNGF Expression and Targeting in Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is the most lethal adult brain cancer. Temozolomide (TMZ), the standard chemotherapeutic drug used in GBM, has limited benefit and alternate therapies are needed to improve GBM treatment. Nerve growth factor (NGF) and its precursor proNGF are increasingly recognized as...
Autores principales: | Marsland, Mark, Dowdell, Amiee, Faulkner, Sam, Jobling, Phillip, Rush, Robert A., Gedye, Craig, Lynam, James, Griffin, Cassandra P., Baker, Mark, Marsland, Joanne, Jiang, Chen Chen, Hondermarck, Hubert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863529/ https://www.ncbi.nlm.nih.gov/pubmed/36675126 http://dx.doi.org/10.3390/ijms24021616 |
Ejemplares similares
-
Expression of NGF/proNGF and Their Receptors TrkA, p75(NTR) and Sortilin in Melanoma
por: Marsland, Mark, et al.
Publicado: (2022) -
The Membrane Protein Sortilin Is a Potential Biomarker and Target for Glioblastoma
por: Marsland, Mark, et al.
Publicado: (2023) -
Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy
por: Dowdell, Amiee, et al.
Publicado: (2023) -
ProNGF is a potential diagnostic biomarker for thyroid cancer
por: Faulkner, Sam, et al.
Publicado: (2016) -
The Precursor for Nerve Growth Factor (proNGF) in Thyroid Cancer Lymph Node Metastases: Correlation with Primary Tumour and Pathological Variables
por: Rowe, Christopher W., et al.
Publicado: (2019)